SEC Form 4 · accession 0001042074-17-000010
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Evan A. Stein
Director
Period of report
Jun 28, 2017
Accepted (ET)
Jun 30, 2017 · 2:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.50 | Jun 28, 2017 | A | 15,000 | A | — | Jun 27, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017.